N6-Methyladenosine modification, representing the most abundant epitranscriptomic mark in mammalian cells, serves as a pivotal regulator of immunological processes in cancer, including immune effector functions, chemokine/cytokine cascades, and MHC-mediated antigen display [34]. This evidence concerns the gene HLA-C and cancer.